Loading company…
Allyx Therapeutics, Inc.
PrivateWon 3 federal SBIR/STTR research awards from HHS and other federal agencies.
Biotechnology
- SEC CIK
- 0001865257
- SAM UEI
- J1EHDFKTPBS7
- Founded
- —Source: [SEC]
- Headquarters
- NEW HAVEN, CONNECTICUTSource: [SEC]
- Country
- United StatesSource: [SEC]
- Headcount
- 1Source: [SEC]
- Stage
- Series B
$26.4MSource: [SEC]Total raised
UndisclosedSource: [SEC]Last valuation
Overview
ALLYX THERAPEUTICS INC has been awarded 3 US Small Business Innovation Research (SBIR/STTR) contracts totalling $5,817,445 between 2020 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in NEW HAVEN, Connecticut.
Funding rounds
4 rounds- SBIR Phase I award (HHS)GrantSep 2020Source: [GOV]$450K—post-money
- SBIR Phase II award (HHS)
Investors
No investors recorded yet for Allyx Therapeutics, Inc..
Add an investorPeople
LeadershipShowing 2 of 8 — any approved contribution unlocks every profile for 30 days.Sign in to unlock
Acquisitions
Allyx Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Allyx Therapeutics, Inc..
Add diversity data